Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
-
Stoke Therapeutics Inc. (STOK) surges following 'impressive' study data
-
TD Cowen Upgrades Stoke Therapeutics (STOK) to Buy following STK-001 update
-
Form SC 13G/A Stoke Therapeutics, Inc. Filed by: Cowen Financial Products LLC
-
Form SC 13G Stoke Therapeutics, Inc. Filed by: Cowen Financial Products LLC
-
TD Cowen Downgrades Stoke Therapeutics (STOK) to Market Perform, 'Minimal pipeline progress adds to uncertain outlook'
-
Stoke Therapeutics to Participate at Upcoming March Investor Conferences
-
Form SC 13G/A Stoke Therapeutics, Inc. Filed by: Cowen Financial Products LLC
-
Stoke Therapeutics to Participate in the Cowen 42nd Annual Health Care Conference
-
Form SC 13G Stoke Therapeutics, Inc. Filed by: Cowen Financial Products LLC
-
Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Stoke Therapeutics Inc. (STOK) Prices 2.5M Share Common Offering at $39/Sh
-
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
-
Stoke Therapeutics Inc. (STOK) Announces 2.5M Share Proposed Public Offering
-
Stoke Therapeutics Announces Proposed Public Offering
-
Stoke Therapeutics to Present at 40th Annual Cowen Health Care Conference
-
Cowen Starts Stoke Therapeutics (STOK) at Outperform
-
Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Stoke Therapeutics (STOK) IPO Opens 51% Higher
-
Stoke Therapeutics, Inc. (STOK) Prices 7.89M Share IPO at $18/Sh
-
Stoke Therapeutics Announces Pricing of Initial Public Offering

